Patients with XLRP treated with AGTC-501 gene therapy experienced improvements in visual function including retinal sensitivity . . .

A systematic literature review was conducted to assess available data on disease progression in RPGR-associated XLRP.

Formulate recommendations for designing XLRP gene therapy clinical studies to provide the best chance of successful treatment development.